CVE-2019-12757
Symantec Endpoint Protection (SEP), prior to 14.2 RU2 & 12.1 RU6 MP10 and Symantec Endpoint Protection Small Business Edition (SEP SBE) prior to 12.1 RU6 MP10d (12.1.7510.7002), may be susceptible to a privilege escalation vulnerability, which is a type…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.40%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Symantec Endpoint Protection (SEP), prior to 14.2 RU2 & 12.1 RU6 MP10 and Symantec Endpoint Protection Small Business Edition (SEP SBE) prior to 12.1 RU6 MP10d (12.1.7510.7002), may be susceptible to a privilege escalation vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resources that are normally protected from an application or user.
- CVSS 3.1
- 7.8 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.40% probability · 34th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Affected
- symantec/endpoint protection
- Source
- secure@symantec.com
EPSS 0.4% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://support.symantec.com/us/en/article.SYMSA1488.htmlVendor Advisory
- https://support.symantec.com/us/en/article.SYMSA1488.htmlVendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.